A new bandage that helps treat eczema by balancing skin bacteria
Controlled Release Eczema Bandage (CREB)
This study is testing a new type of bandage that uses a natural ingredient to help calm eczema flare-ups without harming your skin's good bacteria, aiming to offer a gentler treatment option for both kids and adults who struggle with atopic dermatitis.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cfd Research Corporation NIH-funded |
| Lab location | 1 site (Huntsville, United States) |
| Project ID | NIH-10921604 on NIH RePORTER |
What this research studies
This research focuses on developing a novel wet wrap therapy for atopic dermatitis, which is a common skin condition causing eczema. The therapy uses a natural compound that modulates the immune response to soothe eczema flare-ups while being gentle on the skin's beneficial bacteria. The compound is incorporated into cellulose-based fabrics, creating a controlled-release bandage that will be tested in mouse models before potential human application. The goal is to provide an effective treatment option that reduces reliance on steroid ointments for both children and adults.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals of all ages suffering from atopic dermatitis, particularly those who experience frequent flare-ups.
Not a fit: Patients with eczema who do not respond to topical treatments or have other underlying skin conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new standard treatment for eczema that minimizes the need for steroid medications.
How similar studies have performed: Similar approaches using microbiome-balancing therapies have shown promise in other dermatological conditions, suggesting potential success for this novel treatment.
Where this research is happening
Huntsville, United States
- Cfd Research Corporation — Huntsville, United States (Active)
Researchers
- Principal investigator: Singhal, Aj — Cfd Research Corporation
- Study coordinator: Singhal, Aj
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.